In Vivo T Helper Cell Response to Retro-Inverso Peptidomimetics

Journal of Immunology

Volumn 159, Issue 7, 1997, Pages 3230-3237

  Mézière, Chrystelle ^a   Viguier, Mireille ^b   Dumortier, Hélène ^a   Lo Man, Richard ^c   Leclerc, Claude ^c   Guillet, Jean Gérard ^b   Briand, Jean Paul ^a   Muller, Sylviane ^a,d  

^a CNRS   (France)

^b INSTITUT COCHIN   (France)

^c INSTITUT PASTEUR   (France)

^d INSTITUT DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; HLA ANTIGEN CLASS 2; IMMUNOGLOBULIN ALLOTYPE; IMMUNOGLOBULIN G; LYMPHOCYTE ANTIGEN RECEPTOR; PEPTIDE FRAGMENT; VIRUS ANTIBODY; VP1 PROTEIN, POLIOVIRUS;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; HELPER CELL; IMMUNOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOCYTE ACTIVATION; METABOLISM; MOLECULAR GENETICS; MOUSE; POLIOMYELITIS VIRUS; PROTEIN BINDING; SYNTHESIS; VIRUS CAPSID;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; CAPSID; CAPSID PROTEINS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOGLOBULIN ALLOTYPES; IMMUNOGLOBULIN G; INJECTIONS, INTRAPERITONEAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; POLIOVIRUS; PROTEIN BINDING; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0031253957     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Ottenhoff, T. H. M. 1996. Selective modulation of T-cell responses in autoimmunity and cancer. Immunol. Today 17:54.
2. Appella, E., D. J. Loftus, K. Sakaguchi, A. Sette, and E. Celis. 1995. Synthetic antigenic peptides as a new strategy for immunotherapy of cancer. Biomed. Pept. Proteins Nucleic Acids 1:177.
3. van Neerven, R. J. J., C. Ebner, H. Yssel, M. L. Kapsenberg, and J. R. Lamb. 1996. T-cell responses to allergens: epitope-specificity and clinical relevance. Immunol. Today 17:526.
4. Adorini, L., V. Barnaba, C. Bona, F. Celada, A. Lanzavecchia, E. Sercarz, N. Suciu-Foca, and H. Wekerle. 1990. New perspectives on immunointervention in autoimmune diseases. Immunol. Today 11:383.
5. Chiang, B.-L., A. Ansar, and M. E. Gershwin. 1992. Prospects of vaccination in autoimmune diseases. Int. Arch. Allergy Immunol. 98:181.
6. Shoenfeld, Y., M. Blank, R. Aharoni, D., Teitelbaum, and R. Arnon. 1993. Manipulation of autoimmune diseases with T-suppressor cells: lessons from experimental SLE and EAE. Immunol. Lett. 36:109.
7. Sloan-Lancaster, J., and P. M. Allen. 1995. Significance of T-cell stimulation by altered peptide ligands in T-cell biology. Curr. Opin. Immunol. 7:103.
8. Jameson, S. C., and M. J. Bevan. 1995. T-cell receptor antagonists and partial agonists. Immunity 2:1.
9. Karin, N., D. J. Mitchell, S. Brocke, N. Ling, and L. Steinman. 1994. Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T-cell receptor antagonism and reduction of interferon γ and tumor necrosis factor a production. J. Exp. Med. 180:2227.
10. De Magistris, M. T., J. Alexander, M. Coggeshall, A. Altman, F. C. A. Gaeta, H. M. Grey, and A. Sette. 1992. Antigen analog-major histocompatibility complexes act as antagonists of the T-cell receptor. Cell 68:625.
11. Höllsberg, P., W. E. J. Weber, F. Dangond, V. Batra, A. Sette, and D. A. Hafler. 1995. Differential activation of proliferation and cytotoxicity in human T-cell lymphotropic virus type I Tax-specific CD8 T-cells by an altered peptide ligand. Proc Natl. Acad. Sci. USA 92:4036.
12. Nicholson, L. B., J. M. Greer, R. A. Sobel, M. B. Lees, and V. K. Kuchroo. 1995. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity 3:397.
13. Kersh, G. J., and P. M. Allen. 1996. Structural basis for T cell recognition of altered peptide ligands: a single T cell receptor can productively recognize a large continuum of related ligands. J. Exp. Med. 184:1259.
14. Benkirane, N., M. Friede, G. Guichard, J.-P. Briand, M. H. V. Van Regenmortel, and S. Muller. 1993. Antigenicity and immunogenicity of modified synthetic peptides containing D-amino acid residues. J. Biol. Chem. 268:26279.
15. Guichard, G., N. Benkirane, G. Zeder-Lutz, M. H. V. Van Regenmortel, J.-P. Briand, and S. Muller. 1994. Antigenic mimicry of natural L-peptides with retro-inverso-peptidomimetics. Proc. Natl. Acad. Sci. USA 91:9765.
16. Benkirane, N., G. Guichard, M. H. V. Van Regenmortel, J.-P. Briand, and S. Muller. 1995. Cross-reactivity of antibodies to retro-inverso peptidomimetics with the parent protein histone H3 and chromatin core particle. J. Biol. Chem. 270:11921.
17. Muller, S., G. Guichard, N. Benkirane, F. Brown, M. H. V. Van Regenmortel, and J.-P. Briand. 1995. Enhanced immunogenicity and cross-reactivity of retro-inverso peptidomimetics of the major antigenic site of foot-and-mouth disease virus. Pept. Res. 8:138.
18. Briand, J.-P., G. Guichard, H. Dumortier, and S. Muller. 1995. Retro-inverso peptidomimetics as new immunological probes. J. Biol. Chem. 270:20686.
19. Benkirane, N., G. Guichard. J.-P. Briand, and S. Muller. 1996. Exploration of requirements for peptidomimetic immune recognition: antigenic and immunogenic properties of reduced peptide bond pseudopeptide analogues of a histone hexapeptide. J. Biol. Chem. 271:33218.
20. Guichard, G., F. Connan, R. Graff, M. Ostankovitch, S. Muller, J.-G. Guillet, J. Choppin, and J.-P. Briand. 1996. Partially modified retro-inverso pseudopeptides as non-natural ligands for the human class I histocompatibility molecule, HLA-A2. J. Med. Chem. 39:2030.
21. Guichard, G., S. Calbo, S. Muller, P. Kourilsky, J.-P. Briand, and J.-P. Abastado. 1995. Efficient binding of reduced peptide bond pseudopeptides to major histocompatibility complex class I molecule. J. Biol. Chem. 270:26057.
22. Leclerc, C., E. Deriaud, V. Mimic, and S. Van der Werf. 1991. Identification of a T-cell epitope adjacent to neutralization antigenic site 1 of poliovirus type 1. J. Virol. 65:711.
23. b. Eur. J. Immunol. 23:2655.
24. Avery, A. C., Z.-S. Zhao., A. Rodriguez, E. K. Bikoff, M. Soheilian, C. S. Foster, and H. Cantor. 1995. Resistance to herpes stromal keratitis conferred by an IgG2a-derived peptide. Nature 376:431.
25. Neimark, J., and J.-P. Briand. 1993. Development of a fully automated multichannel peptide synthesizer with integrated TFA cleavable capability. Pept. Res. 6:219.
26. King, D., C. Fields, and G. Fields. 1990. A cleavage method which minimizes side reactions following Fmoc solid-phase peptide synthesis. Int. J. Pept. Protein Res. 36:255.
27. Corradin, G., H.-M. Etlinger, and J. M. Chiller. 1977. Lymphocyte specificity to protein antigens. I. Characterization of the antigen-induced in vitro T cell-dependent proliferative response with lymph node cells from primed mice. J. Immunol. 119:1048.
28. Hu-Li, J., J. Ohara, C. Watson, W. Tsang, and W. E. Paul. 1989. Derivation of a T-cell line that is highly responsive to IL-4 and IL-2 (CT.4R) and of an IL-2 hyporesponsive mutant of that line (CT.4S). J. Immunol. 142:800.
29. Guillet, J.-G., M.-Z. Lai, T. J. Briner, S. Buus, A. Sette, H. M. Grey, J. A. Smith, and M. L. Gefter. 1987. Immunological self, nonself discrimination. Science 235: 865.
30. Ngo-Giang-Huong, N., M. Kayibanda, B. Deprez, J.-P. Levy, J.-G. Guillet, and A.-F. Tilkin. 1995. Mutations in residue 61 ofH-Ras p21 protein influence MHC class II presentation. Int. Immunol. 7:269.
31. Frandji, P., C. Oskéritzian, F. Cacaraci, J. Lapeyre, R. Peronet, B. David, J.-G. Guillet, and S. Mecheri. 1993. Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma. J. Immunol. 151:6318.
32. Lo-Man, R., P. Martineau, J.-M. Betton, M. Hofnung, and C. Leclerc. 1994. Molecular context of a viral T-cell determinant within a chimeric bacterial protein alters the diversity of its T-cell recognition. J. Immunol. 152:5600.
33. Hill, C. M., A. Liu, K. W. Marshall, J. Mayer, B. Jorgensen, B. Yuan, R. M. Cubbon, E. A. Nichols, L. S. Wicker, and J. B. Rothbard. 1994. Exploration of requirements for peptide binding to HLA DRB1 *0101 and DRB1 *0401. J. Immunol. 152:2890.
34. + T cell clone. Eur. J. Immunol. 27:1387.
35. Fremont, D. H., W. A. Hendrickson, P. Marrack, and J. Kappler. 1996. Structures of an MHC class II molecule with covalently bound single peptides. Science 272:1001.
36. Evavold, B. D., J. Sloan-Lancaster, and P. M. Allen. 1994. Antagonism of superantigen-stimulated helper T-cell clones and hybridomas by altered peptide ligand. Proc. Natl. Acad. Sci. USA 91:2300.
37. Madrenas, J., R. L. Wange, J. L. Wang, N. Isakov, L. E. Samelson, and R. N. Germain. 1995. ζ phosphorylation without ZAP-10 activation induced by TCR antagonists or partial agonists. Science 267:515.
38. Alexander, J., J. Sidney, S. Southwood, J. Ruppert, C. Oseroff, A. Maewal, K. Snoke, H. M. Serra, R. T. Kubo, A. Sette, and H. M. Grey. 1994. Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. Immunity 1:751.
39. Evavold, B. D., J. Sloan-Lancaster, and P. M. Allen. 1993. Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands. Immunol. Today 14:602.
40. Racioppi, L., F. Ronchese, L. A. Matis, and R. N. Germain. 1993. Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling. J. Exp. Med. 177:1047.
41. Ruppert, J., J. Alexander, K. Snoke, M. Coggeshall, E. Herbert, D. McKenzie, H. M. Grey, and A. Sette. 1993. Effect of T-cell receptor antagonism on interaction between T cells and antigen-presenting cells and on T-cell signaling events. Proc. Natl. Acad. Sci. USA 90:2671.